Sun, Dec 21, 2014, 6:56 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Regenerx Biopharmaceuticals Inc. Message Board

  • snogreen snogreen Nov 18, 2013 11:59 AM Flag

    10-Q filing delayed

    Last Friday RGRX filed with SEC for a delay in giving the 10-Q. They have a 30 day extension till Dec 13. I thought it strange….RGRX statd that the reason they could not file the 10-\Q now was that they have delays in providing some "disclosures". What dislcoures do they have? Every other filing they do is boiler plate. The accounting firm says that they are in trouble……and RGRX lists on every other filing TONS of boilerplate warnings of their pretty dire condition. All RGRX had to do was 'Copy and Paste" every other disclosure they and the accountant have given for a while now. So? That leads me to believe that there is some OTHER disclosure….that is not the usual disclosure they use all the time previous..and that "disclosure" is delayed for some reason. I don't think there are many "band aids" left to do here. The band aids were done to just "hold on".…until they got some piece of news they were waiting on. These latest disclosed Glaxo tests using TB 4 may have been siuch news. So perhaps the disclosure they wait ion is some word from Glaxo…will they license TB 4 and try it in heart? Or if Glaxo says they don't have interest…then I don't see anything else out there to save RGRX. Lee's isn;t doing a damn thing w/ TB 4. And Henry ford was shut out by the USPO for neuro TB 4 patent end of August. I'm not sure H.F. would proceed on something $$$, if they don't have the IP in place to protect their $$ work. So maybe we have our final answer by Dec 15.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
RGRX
0.139+0.007(+5.30%)Dec 19 2:44 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.